Keynote Sessions

• Ophthalmology in OC: Past, Present and Future - October 25, Noon - 1:30 p.m.
• Global Medical Device Industry Update - October 26, 12:15 - 1:45 p.m.
• Healthcare Policy & Reform - October 26, 2:00 - 3:30 p.m.

Ophthalmology in OC: Past, Present and Future
Sponsored by: Bioquest
10/25 Noon - 1:30 p.m.

Matthew Jenusaitis: President and CEO, OCTANe

Matthew Jenusaitis joined as the president and CEO of OCTANe in June, 2009. Prior to OCTANe, Matthew spent 15 years at Boston Scientific Corp., where he served in numerous executive marketing and general management positions. More...

Robert Grant - CEO, President - Global Surgical Business, Bausch + Lomb

Effective August 2010, Robert E. Grant is chief executive officer and president, global Surgical business, Bausch + Lomb. More...






William J. Link, PhD - Managing Director, Versant Ventures

Bill Link specializes in early-stage investing in medical devices at Versant. Prior to co-founding Versant Ventures, Bill was a general partner at Brentwood Venture Capital. More...

Roger F. Steinert, M.D. - Director, Gavin Herbert Eye Institute, University of California, Irvine; Professor and Chair of Ophthalmology

Dr. Steinert's advanced skill and excellent surgical results have earned him a reputation as an international consultant and leader in cataract surgery, refractive surgery, and corneal transplants. More...

Global Medical Device Industry Update
Sponsored by: PricewaterhouseCoopers
10/26 12:15 - 2:00 p.m.

Mark Leahey, President & CEO, MDMA

Mark Leahey is the President & CEO for the Medical Device Manufacturers Association (MDMA), a national trade association in Washington, DC that represents research-driven medical technology companies. More...

John S. Moran: Managing Director, PricewaterhouseCoopers

John is a Managing Director in our Pharma and Life Science practice focused on assisting clients with advisory services that achieve sustainable competitive advantage through strategic change. More...

Doug Mowen: Managing Director, PricewaterhouseCoopers

Mr. Mowen is a Managing Director in the US Life Sciences advisory practice with responsibility for the medical device industry. More...

Scott Whitcup: Executive Vice President, Research and Development, Chief Scientific Officer - Allergan

Dr. Whitcup is the Executive Vice President, R&D and Chief Scientific Officer at Allergan.  He is on the faculty at the Jules Stein Eye Institute/David Geffen School of Medicine at UCLA and also serves as a Director on the Board of Avanir Pharmaceuticals. More...

The 2010 Mid Term Elections & Healthcare Reform:
What it all means for the Medical Device Industry
10/26 2:00 - 3:30 p.m.

With the Mid-Term elections one week away and the process of implementation of the new healthcare law now nine months in, reforms and financial implications will have a deep impact on the medical device industry, every CEO and industry investor needs to understand how they will be affected. Here, leading experts will discuss what's ahead for our industry and what the Mid-Term elections will mean for the entire life science sector.

Matthew Jenusaitis: President and CEO, OCTANe

Matthew Jenusaitis joined as the president and CEO of OCTANe in June, 2009. Prior to OCTANe, Matthew spent 15 years at Boston Scientific Corp., where he served in numerous executive marketing and general management positions. More...

Jeffrey J. Kimbell: President, Jeffrey J. Kimbell & Associates

Jeffrey J. Kimbell, President of Jeffrey J. Kimbell & Associates, represents clients in the life sciences community seeking legislative remedies for their needs. Mr. Kimbell specializes in representing life science companies before the U.S. government. More...

Michael A. Mussallem - Chairman and CEO, Edwards Lifesciences

Michael A. Mussallem is chairman and chief executive officer of Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring. 

Mussallem has headed Edwards Lifesciences since it was spun off from Baxter International Inc. and began operating as an independent, publicly traded company (NYSE:EW) in April 2000.  More...

Jane Rady - Divisional VP, Business Development and Communications,

Abbott Medical Optics Inc.

Jane E. Rady is divisional vice president, business development and communications at Abbott Medical Optics (AMO). Prior to AMO’s acquisition by Abbott in 2009, Jane served as executive vice president, strategy and corporate development at Advanced Medical Optics from February 2007 to February 2009. More...

Jon W. Salveson: Vice Chairman, Investment Banking - Piper Jaffray

Jon Salveson is the Vice Chairman of Investment Banking.  Prior to his current position, Jon was the Global Head of Investment Banking for seven years.  Jon is involved in a full range of investment banking activities which include public and private equity and debt financings, mergers and acquisitions advisories and financial advisory services. More...